Literature DB >> 629494

Respiratory dyskinesias: extrapyramidal dysfunction and dyspnea.

W J Weiner, C G Goetz, P A Nausieda, H L Klawans.   

Abstract

Four patients had acute dyspnea and chest pain due to primary neurologic disease, not to cardiac or pulmonary disorders. They suffered from severe, involuntary respiratory dyskinesias, which resulted in an irregular respiratory rate, shortness of breath, and chest discomfort. These respiratory dyskinesias occurred as one aspect of more generalized choreiform movement disorders. Three patients had neuroleptic-induced tardive dyskinesias, and one had levodopa-induced dyskinesias. As a result of their ages and the nature of their complaints, some of these patients were originally thought to have cardiac and pulmonary disorders. Respiratory dyskinesias should be considered as a possible cause of respiratory distress in patients with extrapyramidal dysfunction.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 629494     DOI: 10.7326/0003-4819-88-3-327

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  8 in total

1.  Levodopa-induced breathing, cognitive and behavioral changes in Parkinson's disease.

Authors:  Nicola Tambasco; Vincenzo Belcastro; Antongiulio Gallina; Anna Castrioto; Paolo Calabresi; Aroldo Rossi
Journal:  J Neurol       Date:  2011-06-08       Impact factor: 4.849

2.  Antipsychotic drugs: sudden cardiac death among elderly patients.

Authors:  Puneet Narang; Mostafa El-Refai; Roop Parlapalli; Lilia Danilov; Sainath Manda; Gagandeep Kaur; Steven Lippmann
Journal:  Psychiatry (Edgmont)       Date:  2010-10

3.  Laryngeal tardive dyskinesia.

Authors:  A Fève; B Angelard; J Lacau St Guily
Journal:  J Neurol       Date:  1995-07       Impact factor: 4.849

Review 4.  Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.

Authors:  Peter M Haddad; Ian M Anderson
Journal:  Drugs       Date:  2002       Impact factor: 9.546

5.  Respiration and sleep in Parkinson's disease.

Authors:  M C Apps; P C Sheaff; D A Ingram; C Kennard; D W Empey
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-12       Impact factor: 10.154

6.  Olanzapine-induced hyperventilation: case report.

Authors:  S Pirzada Sattar; David R Gastfriend
Journal:  J Psychiatry Neurosci       Date:  2002-09       Impact factor: 6.186

Review 7.  Respiratory Function and Dysfunction in Parkinson-Type Neurodegeneration.

Authors:  M Pokusa; D Hajduchova; T Buday; A Kralova Trancikova
Journal:  Physiol Res       Date:  2020-03-27       Impact factor: 1.881

Review 8.  Respiratory Dysfunctions in Parkinson's Disease Patients.

Authors:  Any Docu Axelerad; Alina Zorina Stroe; Oana Cristina Arghir; Daniel Docu Axelerad; Anca Elena Gogu
Journal:  Brain Sci       Date:  2021-05-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.